Qsemble Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$369K	Buy	+7,581	New	+$369K	0.04%	349
2025 Q1	–	Sell	-17,664	Closed	-$695K	–	462
2024 Q4	$695K	Buy	+17,664	New	+$695K	0.09%	253